Day Zero sees positive data with tech to diagnose superbug infections
October 26 2020

Data presented at IDWeek highlights the promise of the company’s new class of diagnostics

Read More
Meet the Winners of the 2020 Havard President’s Innovation Challenge
May 21 2020

DZD recognized as a $25K prize winner for our work in modernizing infectious disease diagnosis and treatment

Read More
CARB-X Grants Day Zero Diagnostics $6.2M for Development of Diagnostic Tool
May 17 2020

Healio’s Infectious Disease News interviews CEO Jong Lee on development of DZD’s culture-free diagnostic system

Read More
Day Zero Diagnostics Wins $6.2M From Accelerator
May 12 2020

CARB-X award to fund DZD’s new technology to rapidly identify pathogens and determine their drug resistance profile

Read More
DZD Using CARB-X Award to Commercialize Antibiotic-Resistance Testing Platform
May 11 2020

360Dx reporter John Gilmore covers DZD’s plans to advance new diagnostic system with CARB-X funding

Read More
CARB-X Awards DZD $6.2M to Develop New Test To Diagnose Deadly Superbug Infections
May 11 2020

Funding award is the first whole genome sequencing and machine learning technology in CARB-X portfolio

Read More
Top